KU ASH 2018 Review: Current Updates in Hematologic Diseases

 

KU ASH 2018 Review: Current Updates in Hematologic Diseases
Avatar

ASH December 2018 - Myeloma - BCMA CAR T Therapy for Refractory Patients

By KU ASH 2018 Review: Current Updates in Hematologic Diseases FEATURING Frederick L. Locke
By KU ASH 2018 Review: Current Updates in Hematologic Diseases FEATURING Frederick L. Locke
235 views
March 19, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Videos
22:39
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - MDS - Top Trials and Key Takeaways

Feat. B. Skikne
25:14
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - MPN - Review and Synthesis of Recent Trials

Feat. A. Yacoub
26:11
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH 2018 Myeloid Neoplasms - How Recent Trials on Stem Cell Transpla…

Feat. A. Singh
28:21
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - Benign Hematolgy - Analysis of Top Trials

Feat. P. Harris
30:39
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - CLL and Indolent Lymphoma - Review of Clinical T…

Feat. M. Hoffmann
21:22
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018- Aggressive Lymphomas: Recent Approvals and Promis…

Feat. A. Vallurupalli
25:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases

MM - Overview of Trials Presented at ASH 2018

Feat. A. Abdallah
06:55
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - Lymphoma- Historical Perspective of CAR-T Cell T…

Feat. F. Locke
24:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018- Lymphoma - Efficacy and Safety from ZUMA 1, JULIE…

Feat. F. Locke
14:52
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - Lymphoma - Axi-cel as Standard of Care and Relat…

Feat. F. Locke
03:50
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - Myeloma - BCMA CAR T Therapy for Refractory Pati…

Feat. F. Locke
23:37
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH 2018 AML: Deciding Between Standard vs Investigational Therapies…

Feat. E. Estey
05:54
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - MRD in AML - What is the Benefit / Risk Ratio Re…

Feat. E. Estey
06:26
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - AML - Allogeneic Hematopoietic Cell Transplantat…

Feat. E. Estey
14:49
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH 2018 AML Challenges in Evaluating New Therapies: Understanding t…

Feat. E. Estey
06:55
KU ASH 2018 Review: Current Updates in Hematologic Diseases

Lymphoma and Myeloma - Cellular Therapy, Efficacy and Safety from Top Tria…

Feat. F. Locke
23:37
KU ASH 2018 Review: Current Updates in Hematologic Diseases

AML - Keynote - Latest updates on Standard Therapies and Investigati…

Feat. E. Estey